Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles: 2009-2018

Historic Amortizatization of Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Dec 2018 value amounting to $8.1 million.

  • Ironwood Pharmaceuticals' Amortizatization of Intangibles rose 8.40% to $426,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 28.90%. This contributed to the annual value of $8.1 million for FY2018, which is 30.53% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $8.1 million for FY2018, which was up 30.53% from $6.2 million recorded in FY2017.
  • Ironwood Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $8.1 million during FY2018, with a 5-year trough of -$1.1 million in FY2015.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Amortizatization of Intangibles value was $6.2 million (recorded in 2017), while the average stood at $5.1 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Amortizatization of Intangibles declined by 2.67% in 2015 and then surged by 533.44% in 2017.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Amortizatization of Intangibles stood at -$1.1 million in 2014, then fell by 2.67% to -$1.1 million in 2015, then soared by 188.06% to $981,000 in 2016, then skyrocketed by 533.44% to $6.2 million in 2017, then surged by 30.53% to $8.1 million in 2018.